Myeloid Differentiation Factor 2 Inhibition Attenuates Brain Pathologies in the Obese Pre‐diabetic Condition
These findings suggest that MD-2 inhibition could be the potential strategy for attenuating brain dysfunctions in the obese pre-diabetic condition.
Authors
- Thura Tun Oo
- Wasana Pratchayasakul (ORCID: https://orcid.org/0000-0003-3970-4323)
- Titikorn Chunchai (ORCID: https://orcid.org/0000-0003-4405-1208)
- Busarin Arunsak (ORCID: https://orcid.org/0000-0002-5120-288X)
- Nattayaporn Apaijai (ORCID: https://orcid.org/0000-0002-1265-5210)
- Guang Liang (ORCID: https://orcid.org/0000-0002-8278-849X)
- Siriporn C. Chattipakorn (ORCID: https://orcid.org/0000-0003-1677-7052)
- Wichwara Nawara
- Nipon Chattipakorn
Institutions
- Wenzhou Medical University (CN)
- Chiang Mai University (TH)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.084629
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00